HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Related articles in JNM Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bettio, A. Articles by Ametamey, S. M. Search for Related Content PubMed PubMed Citation Articles by Bettio, A. Articles by Ametamey, S. M.

Synthesis and Preclinical Evaluation of a Folic Acid Derivative Labeled with ¹⁸F for PET Imaging of Folate Receptor–Positive Tumors

¹ Department of Chemistry and Applied Biosciences of ETH, Center for Radiopharmaceutical Science of ETH, PSI, and USZ, Zurich, Switzerland; ² Department of Nuclear Medicine, Cantonal Hospital, Aarau, Switzerland; and ³ Merck Eprova AG, Schaffhausen, Switzerland

Correspondence: For correspondence or reprints contact: Simon M. Ametamey, PhD, Center for Radiopharmaceutical Science of ETH, PSI, and USZ, ETH Hönggerberg Wolfgang Pauli Strasse 10, CH-8093 Zurich, Switzerland. E-mail: simon.ametamey{at}pharma.ethz.ch

Folic acid was linked regioselectively through its - and -carboxyl groups to 4-fluorobenzylamine (FBA), and the - and -FBA-folate regioisomers were evaluated for their ability to bind to folate receptor–positive cells. The ¹⁸F-labeled /-FBA-folate counterpart was examined for in vivo tumor targeting efficiency in nude mice bearing folate receptor–positive tumor cells. Methods: ¹⁸F-/-FBA-folate was prepared in a 4-step reaction sequence starting from folic acid. The relative binding affinities of the - and -FBA-folates to the folate receptor with respect to parent folic acid were determined in cultured KB-31 cells (nasopharyngeal epidermal carcinoma cell line) overexpressing the folate receptor using ³H-folic acid. Tumor accumulation of the ¹⁸F-labeled /-FBA-folate and ¹⁸F-FDG was analyzed in vivo by high-resolution PET. Biodistribution and PET studies were performed under baseline and blockage conditions. Results: The radiochemical yield of the coupling step ranged from 15% to 44%, and the maximum specific radioactivity was 24 GBq/µmol. The in vitro binding affinities of the - and -isomers and folic acid were 71, 62, and 41 nmol/L, respectively. PET revealed heterogeneous uptake of the radioligand, with the highest activity concentrations found in the tumor rim. In contrast, ¹⁸F-FDG uptake in a nude mouse bearing KB-31 folate receptor–positive tumors was negligible. Radioligand uptake in tumors at 125 min after injection amounted to 6.56% of the injected dose per gram of tissue (%ID/g) in control animals, whereas radioactivity accumulation in the tumors of folic acid–treated animals was significantly reduced by more than 80%—to 1.07 %ID/g (P = 0.001). Conclusion: This new ¹⁸F-labeled folic acid derivative is a promising tool for PET imaging of folate receptor–positive tumors.

Key Words: folate receptor • ¹⁸F labeling • PET • tumor imaging

Related articles in JNM:

This Month in JNM

JNM 2006 47: 11a-12a. [Full Text]  

This article has been cited by other articles:

				C. Muller, R. Schibli, E. P. Krenning, and M. de Jong Pemetrexed Improves Tumor Selectivity of 111In-DTPA-Folate in Mice with Folate Receptor-Positive Ovarian Cancer J. Nucl. Med., April 1, 2008; 49(4): 623 - 629. [Abstract] [Full Text] [PDF]

				C. Muller, F. Forrer, R. Schibli, E. P. Krenning, and M. de Jong SPECT Study of Folate Receptor-Positive Malignant and Normal Tissues in Mice Using a Novel 99mTc-Radiofolate J. Nucl. Med., February 1, 2008; 49(2): 310 - 317. [Abstract] [Full Text] [PDF]